Purchases and Sales Made in Q2 2023 in Indaptus Therapeutics, Inc. (INDP)
This table provides information about the institutional ownership of Indaptus Therapeutics, Inc. (INDP) during Q2 2023. The information is specifically focused on institutions that hold shares of Indaptus Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2023
Q2 2023
|
Investment House LLC
Las Vegas, NV |
BUY
|
- |
12.7K+ 13.23% |
$20.2K - $38.5K
|
108K
$127K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1.6K+ 8.33% |
$2.56K - $4.86K
|
20.8K
$24.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
640New |
$1.02K - $1.95K
|
640
$749
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 2.02% |
$3.2 - $6.08
|
101
$118
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-475- 7.74% |
$760 - $1.44K
|
5.67K
$6.63K
|
|
|
Aug 24, 2023
Q2 2023
|
Strategy Asset Managers LLC
|
SELL
|
- |
-10K- 18.07% |
$16K - $30.4K
|
45.3K
$53K
|